Beijing Health (Holdings) Limited provided consolidated earnings guidance for the period ended 30 June 2022. Based on the preliminary assessment of the Group's unaudited consolidated management accounts for the period ended 30 June 2022 and the information currently available to the Company, it is expected that loss attributable to the owners of the Company for the period ended 30 June 2022 will increase by approximately HKD 21 million as compared with the corresponding period in 2021. The principal reasons for the increase in loss are as follows: Exchange losses of approximately HKD 1.67 million were recorded for the current period due to the depreciation of RMB and CAD, and exchange gains of approximately HKD 8.57 million were recorded for the corresponding period of previous year; and For the corresponding period of previous year, a reversal of impairment on the investments in associates amounted to approximately HKD 13.53 million, and the reversal of impairment of assets in similar nature was absent for the current period.